Q2 FY2026 · ended Jun 30, 2026 · Revenue $4.17M, -10.5% YoY · Filed Aug 13, 2026
Marpai, Inc. (MRAI) files with the SEC under industry code 8090, Services-Misc Health & Allied Services, NEC. In Q2 of fiscal 2026, the quarter ended Jun 30, 2026, it reported revenue of $4.2 million and a net loss of $4.6 million. As of Jun 30, 2026 it held $138,000 in cash and investments and $25.9 million in total debt.
Revenue
$4.17M
-10.5% vs year-ago quarter
Net income
$-4.58M
-4.9% vs year-ago quarter
Operating cash flow
$-4.10M
-27.7% vs year-ago quarter
Free cash flow
—
EPS
$-0.18
+35.7% vs year-ago quarter
Dividend per share
None
Shares outstanding
26.83M
+55.4% vs year-ago quarter
Net cash
$-25.76M
Q2 FY2026
Operating margin
-81.8%
TTM
Company profile
- Industry
- Services-Misc Health & Allied Services, NEC (SIC 8090)
- Listed as
- MRAI (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Tampa, FL
- SEC filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 1844392
Other Services-Misc Health & Allied Services, NEC companies
- Fresenius Medical Care AG FMS
- Davita Inc. DVA
- Sotera Health Co SHC
- Progyny, Inc. PGNY
- agilon health, inc. AGL
- Charming Medical Ltd MCTA
- Viemed Healthcare, Inc. VMD
- Park Dental Partners, Inc. PARK
All 15 Services-Misc Health & Allied Services, NEC companies
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 30, 2025 |
Q2 FY2025 Jun 30, 2025 |
|---|---|---|---|---|---|
| Revenue | $4.2M | $4.4M | $4.0M | $4.0M | $4.7M |
| Operating income | -$3.4M | -$2.5M | -$4.9M | -$2.8M | -$3.6M |
| Net income | -$4.6M | -$3.2M | -$5.6M | -$3.5M | -$4.4M |
| Diluted EPS | -$0.18 | -$0.13 | -$0.26 | -$0.20 | -$0.28 |
| Operating cash flow | -$4.1M | -$477,000 | -$4.8M | $634,000 | -$3.2M |
| Total assets | $9.5M | $10.9M | $10.9M | $12.8M | $11.1M |
| Total liabilities | $48.4M | $46.2M | $43.5M | $46.1M | $43.4M |
| Stockholders' equity | -$38.9M | -$35.2M | -$32.6M | -$33.3M | -$32.4M |
| Cash and investments | $138,000 | $201,000 | $133,000 | $445,000 | $619,000 |
| Total debt | $25.9M | $30.9M | $31.2M | $19.8M | $19.4M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Aug 13, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Bylaw or fiscal year change, Other events
|
Jul 31, 2026 | Jul 29, 2026 |
| 8-K |
Current report
Material agreement, Other events
|
Jul 20, 2026 | Jul 16, 2026 |
| 10-Q | Quarterly report | May 15, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Material agreement
|
May 1, 2026 | Apr 29, 2026 |
| 10-K | Annual report | Mar 25, 2026 | Dec 31, 2025 |
All 339 Marpai, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.